VanEck Biotech ETF (NASDAQ:BBH) Sees Unusually-High Trading Volume – Here’s What Happened

VanEck Biotech ETF (NASDAQ:BBH) shares saw strong trading volume on Friday. 10,143 shares were traded during trading, an increase of 36% from the average daily volume of 7,443 shares. The stock last traded at $259.4760 and had previously closed at $256.90.

VanEck Biotech ETF Trading Up 0.5%

The firm’s 50-day simple moving average is $240.60 and its 200 day simple moving average is $206.44.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the business. Coastline Trust Co bought a new position in shares of VanEck Biotech ETF during the third quarter valued at about $46,000. CoreCap Advisors LLC bought a new stake in VanEck Biotech ETF during the third quarter worth about $46,000. SBI Securities Co. Ltd. bought a new position in shares of VanEck Biotech ETF during the 3rd quarter valued at $74,000. Manchester Capital Management LLC purchased a new position in shares of VanEck Biotech ETF in the third quarter worth $74,000. Finally, First PREMIER Bank bought a new position in shares of VanEck Biotech ETF during the second quarter valued at approximately $91,000. Institutional investors own 32.05% of the company’s stock.

VanEck Biotech ETF Company Profile

The BIOTECH HOLDING COMPANY DEPOSITARY RECEIPTS or HOLDRS TRUST was formed under the depositary trust agreement, among The Bank of New York, as trustee, Merrill Lynch, Pierce, Fenner & Smith Incorporated, other depositors and the owners of the Biotech HOLDRS. The trust currently holds shares of common stock or American depositary shares issued by a group of companies that were, at the time of the initial offering, generally considered to be involved in various segments of thebiotechnology industry.